| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/10/2002 | WO2001046417A3 Human membrane proteins and polynucleotides encoding the same having homology to cd20 proteins and ige receptors |
| 01/10/2002 | WO2001045730A3 Tweak receptor |
| 01/10/2002 | WO2001045639A3 Methods for protecting against lethal infection with bacillus anthracis |
| 01/10/2002 | WO2001045495A3 Potassium channel stress-related proteins and methods of use in plants |
| 01/10/2002 | WO2001044289A3 Modified leukotoxin gene and protein |
| 01/10/2002 | WO2001044269B1 Brain protein markers |
| 01/10/2002 | WO2001043691A3 Fragments and antagonists of heat shock protein 60 |
| 01/10/2002 | WO2001042466A3 Zvwf1: a member of the von willebrand factor type a domain superfamily |
| 01/10/2002 | WO2001042444A3 Methods for expression of genes in primates |
| 01/10/2002 | WO2001040755A3 A novel and practical serological assay for the clinical diagnosis of leishmaniasis |
| 01/10/2002 | WO2001040279A3 Hbv sequences |
| 01/10/2002 | WO2001040276A3 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 01/10/2002 | WO2001040270A3 A major neutralization site of hepatitis e virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies |
| 01/10/2002 | WO2001038358A3 Hbv/hcv virus-like particle |
| 01/10/2002 | WO2001038344A3 Modulation of signal transduction |
| 01/10/2002 | WO2001037896A3 Methods and compositions for administration of therapeutic reagents |
| 01/10/2002 | WO2001036621A3 Down-regulation and silencing of allergen genes in transgenic peanut seeds |
| 01/10/2002 | WO2001036474A3 Srik a novel cell cycle protein associated with rip3 |
| 01/10/2002 | WO2001036472A3 Compositions and methods for regulating tumor-associated antigen expression |
| 01/10/2002 | WO2001036458A3 Drosophila ced-6 homologue |
| 01/10/2002 | WO2001036452A3 Heteroclitic analogs of class i epitodes |
| 01/10/2002 | WO2001034633A3 Methods for treatment of human huntington's disease and methods of screening for active agents |
| 01/10/2002 | WO2001030971A3 Novel molecules and the card-related protein family and uses thereof |
| 01/10/2002 | WO2001029254A3 Identification of bpesc1, a gene disrupted by a balanced chromosomal translocation t(3;4) (q23;p15.2) in a patient with bpes |
| 01/10/2002 | WO2001029217A3 Novel polypeptides and polynucleotides encoding same |
| 01/10/2002 | WO2001025410A3 DIAGNOSTIC PROBES AND THERAPEUTICS TARGETING uPA AND uPAR |
| 01/10/2002 | WO2001018050A3 T2r taste receptor family |
| 01/10/2002 | WO2001016305A3 Nucleotide sequences encoding an insectidal protein complex from serratia |
| 01/10/2002 | WO2001012664A3 Notch receptor ligands and uses thereof |
| 01/10/2002 | WO2001011048B1 Therapeutic polypeptides and methods for using same |
| 01/10/2002 | WO2001000829A3 Human endogenous retrovirus in breast cancer |
| 01/10/2002 | WO2001000806A3 Dna's encoding proteins with signal peptides |
| 01/10/2002 | WO2001000661A3 Carnitine carrier related protein-1 |
| 01/10/2002 | WO2000075347A3 Tet repressor-based transcriptional regulatory proteins |
| 01/10/2002 | WO2000075300A3 Methods for manipulating the avian genome |
| 01/10/2002 | WO2000066162A9 Mutant human cd80 and compositions for and methods of making and using the same |
| 01/10/2002 | WO2000055332A3 Human regulators of intracellular phosphorylation |
| 01/10/2002 | US20020004944 Transgenic plant; for use in the prevention of microorganism infection in plants |
| 01/10/2002 | US20020004943 Nucleotide sequences coding plant polypeptide; for use in the generation of transgenic plants of preferential phenotypes |
| 01/10/2002 | US20020004942 Transgenic plant that expresses luciferase; for use in the development of toys, foods, textiles and beverages that glow |
| 01/10/2002 | US20020004940 Novel defense induced genes and uses thereof |
| 01/10/2002 | US20020004939 Methods for identifying transgenic plants using morphological markers |
| 01/10/2002 | US20020004938 Models of prion disease |
| 01/10/2002 | US20020004937 Method for detecting an aberrant animal-derived prion gene and a prion gene modified mouse which exhibits heart anomalies |
| 01/10/2002 | US20020004706 Apparatus and method for automated protein design |
| 01/10/2002 | US20020004658 Multiple beam laser sculpting system and method |
| 01/10/2002 | US20020004589 Detecting sensitivity to kidney disease |
| 01/10/2002 | US20020004586 Prion-binding activity in serum and proteins |
| 01/10/2002 | US20020004583 Gene that imparts selective proliferation activity |
| 01/10/2002 | US20020004582 Gene that imparts selective proliferation activity |
| 01/10/2002 | US20020004581 Polypeptide; for use in te diagnosis and treatment of microorganismal infections; bactericides |
| 01/10/2002 | US20020004580 Polypeptide; for use in the diagnosis and treatment of microorganismal infections; bactericides |
| 01/10/2002 | US20020004531 Nitrone inhibition of cancer development |
| 01/10/2002 | US20020004491 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 01/10/2002 | US20020004489 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | US20020004485 Administering oligopeptide |
| 01/10/2002 | US20020004483 Polypeptides, genetic engineering |
| 01/10/2002 | US20020004482 Treatment of acute lung injury and fibrosis with antagonists of avbeta6 |
| 01/10/2002 | US20020004481 Controlled release microencapsulated ngf formulation |
| 01/10/2002 | US20020004479 Biodegradable inserts |
| 01/10/2002 | US20020004239 Nucleotide sequences coding genetically engineered polypeptide; for use in the treatment of mammary gland cancer |
| 01/10/2002 | US20020004238 Inducing immune response by administration of a recombinant protein; obtain cells, transform, propagate, inject into mammals, monitor immune response |
| 01/10/2002 | US20020004232 Nucleotide sequences coding proteins for use in the treatment and prevention of cancer |
| 01/10/2002 | US20020004227 Nucleotide sequences coding immunoglobulins; for use in treating cancer |
| 01/10/2002 | US20020004226 Soluble LDL receptor, its production and use |
| 01/10/2002 | US20020004225 Activating bone development in mammals; prepare activator, adminster to mammal, monitor mammal for bone development |
| 01/10/2002 | US20020004224 Polypeptide; for use in the treatment of sepsis, adult respiratory distress syndrome, pancreatitis, and hemorrhagic shock |
| 01/10/2002 | US20020004223 Polypeptide; for use in the diagnosis and treatment of cancer |
| 01/10/2002 | US20020004222 Polypeptide; for treatment of infections, viral disease, pain, cancers, diabetes, eating disorders, asthma, heart defects Parkinson's and huntington's disease, hypotension, hypertension, urogenital disorders and osteoporosis |
| 01/10/2002 | US20020004221 Apoptosis modulator; for use in prevention of apoptosis; for use in evaluation of eye develpment |
| 01/10/2002 | US20020004215 Adjusting preferental particles to generate signal; mix ligand and marker, enzyme, incubate, allow binding, detect signal |
| 01/10/2002 | US20020004210 Calcium-independent negative regulation by cd81 of receptor signalling |
| 01/10/2002 | US20020004208 Generating nicotine antibodies in situ |
| 01/10/2002 | US20020004193 Novel MP-7 protein and nucleic acid molecules and uses therefor |
| 01/10/2002 | US20020004076 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 01/10/2002 | US20020004048 Hepatitis C virus asialoglycoproteins |
| 01/10/2002 | US20020004047 DNA encoding a novel RG1 polypeptide |
| 01/10/2002 | US20020004042 Gene therapy for pulmonary edema using adenovirus vectors encoding a beta2adrenergic receptor gene |
| 01/10/2002 | US20020004040 Complementary adenoviral vector systems and cell lines |
| 01/10/2002 | US20020004037 Variant type II TGF-beta receptor fusion proteins and methods |
| 01/10/2002 | CA2630062A1 Methods for treating graft versus host disease and immune disorders associated with rejection using a soluble ctla4 molecule |
| 01/10/2002 | CA2416292A1 Transgenic mice containing targeted gene disruptions |
| 01/10/2002 | CA2415123A1 Novel fibroblast growth factors and nucleic acids encoding same |
| 01/10/2002 | CA2415075A1 Novel secreted proteins |
| 01/10/2002 | CA2414995A1 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression |
| 01/10/2002 | CA2414966A1 A pharmaceutical component based on human parathyroid hormone and a pharmaceutical composition for intranasal administration containing the component |
| 01/10/2002 | CA2414884A1 Immunisation against chlamydia pneumoniae |
| 01/10/2002 | CA2414727A1 Elicitor from cladosporium |
| 01/10/2002 | CA2414650A1 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 01/10/2002 | CA2414621A1 Gene expression in biological conditions |
| 01/10/2002 | CA2414596A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/10/2002 | CA2414594A1 Process for the measurement of dinophysistoxin and of yessotoxin |
| 01/10/2002 | CA2414497A1 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 01/10/2002 | CA2414328A1 Chimeric promoters for controlling expression in smooth muscle cells |
| 01/10/2002 | CA2413715A1 Grf2-binding proteins and applications thereof |
| 01/10/2002 | CA2413262A1 B7-like molecules and uses thereof |
| 01/10/2002 | CA2413250A1 The nip3 family of proteins |
| 01/10/2002 | CA2413237A1 Alteration of cell membrane for new functions |
| 01/10/2002 | CA2413186A1 Extracellular matrix and cell adhesion molecules |
| 01/10/2002 | CA2413166A1 Acid-modified arabinogalactan protein composition |